Furun is mainly engaged in R&D and production of  APIs and intermediates, including Dabigatran etexilate ◆Edoxaban ◆Ivabradine hydrochloride ◆Lafutidine ◆Liranaftate ◆Olopatadine hydrochloride ◆Febuxostat ◆Zopidem tartrate Zolpidem tartrate Napidil ◆Propiverine hydrochloride ◆Tofacitinib, etc. The main products produced and operated by the company are: the main products of natural extraction are lentinan, liquiritin, syringin, hollyside, borneol and other natural raw materials; All the products are available for the international market, distributed to Europe, the United States, Asia-Pacific, Hong Kong, Taiwan and other more than 20 countries and regions. The regulatory work is also in intensive preparation, in order to further develop the regulated market, showing a broader development future. The company regards quality as the core of the enterprise, the credibility as the soul, and mutual benefit as the purpose, dedicated to serving the vast number of customers at home and abroad.

20161221143002 5937